It really is unbelievable the silence and lack of contact info from nspx. It's like they have money bags Sabby and need nor care from any other investors. So many questions could be answered. Like why have they totally jettisoned Mipsagargin? The CEO is a figurehead and Hislop has a full time job at Eiger.. why not hire a CMO to handle all the details of moving the patents, portfolio and RT-AR001 forward? Once RT-AR001 gets approval for clinical trials is NSPX going to go it alone or do they license, partner or sell the platform. These type questions will never be answered because nobody home to answer them or do they care. Its a buyer beware situation that with the DD that is out there may have fundamental future value in the drug platforms but realize that NSPX will do nothing or have done nothing to communicate to share holders to validate their investment. The only strategy that makes sense at these prices is hold to see what happens.
News 
Market Data 
Discover 
AI
